Clinical trial
Effects of Coenzyme Q10 Supplement on Cardiovascular Risk Factors in Subjects at High Risk of Metabolic Syndrome
NCT06506630 is registered in ClinicalTrials.gov with Tian Zezhong as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Coenzyme Q10 Supplement on Cardiovascular Risk Factors in Subjects at High Risk of Metabolic Syndrome
- Lead sponsor
- Tian Zezhong
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 11, 2023
- Completion date
- December 30, 2024
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.